Screener
iRadimed IRMD Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Sales and marketing | 4,052 | 4,176 |
| Research and development | 956 | 624 |
| Total operating expenses | 9,577 | 9,411 |
| Income from operations | 7,237 | 5,432 |
| Other income, net | 532 | 513 |
| Income before provision for income taxes | 7,769 | 5,945 |
| Provision for income tax expense | 1,951 | 1,258 |
| Net income | $5,818 | $4,687 |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's operating income?
- iRadimed (IRMD) reported operating income of $7.24M in Q1 2026.
- How has iRadimed's operating income changed year-over-year?
- iRadimed's operating income increased by 33.2% year-over-year, from $5.43M to $7.24M.
- What is the long-term trend for iRadimed's operating income?
- Over 4 years (2021 to 2025), iRadimed's operating income has grown at a 27.7% compound annual growth rate (CAGR), from $9.82M to $26.15M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about iRadimed's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude